Biotoscanaがユナイテッド・メディカルの買収契約を締結し、ブラジルにおける商業的プレゼンスを拡大するとともに南米地域で冠たるスペシャルティ製薬会社...
コロンビア・ボゴタ & サンパウロ (ビジネスワイヤ) — コロンビア・ボゴタを拠点とする製薬会社で、アドベント・インターナショナルとEssex Woodlandsが過半数を所有するGrupo Biotoscana...
View ArticleBioline Expands into Singapore
CINCINNATI Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), is proud to announce the opening of an office in Singapore to support and grow the Bioline...
View ArticlePromega ViaFect™ Transfection Reagent Delivers High Performance Transfection...
Smart Multimedia Gallery ViaFect(TM) Transfection Reagent offers high performance transfection in a diversity of cell lines and iPSC-derived tissue cells. (Photo: Business Wire) View and Share Photo...
View ArticleResearch Confirms Effectiveness Of Cognigram; New Test For Alzheimer’s Disease
MELBOURNE, Australia For patients over the age of 50, a routine physical exam at the doctor’s office typically covers a wide spectrum of medical biomarkers with one glaring exception, cognitive...
View ArticleBiotoscana同意收购United Medical,以拓展在巴西的业务,并在南美打造领先的区域特种制药公司
哥伦比亚波哥大与圣保罗 (美国商业资讯)–由Advent International和Essex Woodlands控股的哥伦比亚波哥大制药公司Grupo Biotoscana SL今天宣布,该公司已签署协议,收购巴西圣保罗集团公司United...
View ArticleKCI负压伤口疗法伴滴注增刊发表于国际伤口杂志
圣安东尼奥 (美国商业资讯)–Kinetic Concepts, Inc.今天宣布,《国际伤口杂志》(IWJ)近期发布了一份增刊,该增刊总结了伤口治疗的现有挑战和实践,呈报了V.A.C. VeraFlo™滴注疗法(NPWTi)用于污染或复杂伤口清洗和治疗的证据和临床经验。该增刊基于2012年和2013年国际外科伤口论坛上的呈报,这些论坛揭示了现代伤口治疗挑战和技术方面的专家研究。...
View ArticleKCIの洗浄併用陰圧創傷治療を扱ったInternational Wound Journal誌特集号が発行
サンアントニオ (ビジネスワイヤ) — キネティック・コンセプツ(KCI)は本日、International Wound Journal(IWJ)誌の特集号がこのほど発行されたと発表しました。この特集号は現在の創傷ケアの課題と実践について要点を述べ、汚染創または複雑な創傷の洗浄と治療のためのV.A.C. VeraFlo™ Instillation...
View ArticlePerkinElmer Introduces Novel Research Tools to Accelerate Discovery of More...
Smart Multimedia Gallery PerkinElmer introduces the Opera(R) Phenix, a next generation confocal high content screening system that is designed to reliably discriminate phenotypes of complex cellular...
View ArticleCerebain Biotech Corp. Announces Engagement of Consultant for Representation...
DALLAS Cerebain Biotech Corp. (“Cerebain” or “the Company”), a subsidiary of Discount Dental Materials, Inc. (OTCBB: DDOO), announced today that it has engaged John Ballard to represent the Company...
View ArticlePerkinElmer在实验室自动化和筛查学会(SLAS) 2014年年会上推出新型科研工具,以加快发现用于治疗威胁生命的疾病的更有效药物
Smart Multimedia Gallery PerkinElmer introduces the JANUS(R) chemagic automated nucleic acid workstation that offers high throughput DNA and RNA extraction with four times the yield and twice the...
View ArticleTerumo BCT Exclusive Therakos Inc. Distributor
LAKEWOOD, Colo. Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, has entered into a business relationship with Therakos, Inc., a global leader in...
View ArticleCovidien Launches Advanced Medical Training and Education Center in India
MUMBAI, India Further developing its capabilities in a key emerging market, Covidien (NYSE:COV) has officially opened its first training and education center in India. The Covidien Center of...
View ArticleWipro Cited as a Leader in Worldwide Life Science Manufacturing and Supply...
BANGALORE, India & EAST BRUNSWICK, New Jersey Wipro Ltd. (NYSE:WIT), a leading global information technology, consulting and outsourcing company has been named ‘Leader’ by technology global...
View ArticleInvestment Bridge Announces Investment Opinion: Bridge Report on R-Tech Ueno...
TOKYO Investment Bridge, one of Japan’s leading independent IR services companies, has released a “Bridge Report” on R-Tech Ueno, Ltd. (JASDAQ:4573) reviewing the results for the first half and...
View Articleヒルコ・ストリームバンク、エアリス・セラピューティクスの資産売却を担当
シカゴ (ビジネスワイヤ) — ヒルコ・グローバルの1ユニットのヒルコ・ストリームバンクは本日、肺気腫患者の非外科的治療に関する革新企業のエアリス・セラピューティクスの資産売却を実施するよう指名されたと発表しました。すべての入札は、2014年2月28日午後5時(米国東部時間)までに締め切られます。...
View Article康泰伦特提交IPO注册申请
新泽西州萨默塞特 (美国商业资讯)–康泰伦特药业(Catalent Pharma Solutions)今日宣布,康泰伦特有限公司 (Catalent,...
View ArticleBioTime, Inc. Subsidiary OncoCyte Corporation Initiates Clinical Development...
ALAMEDA, Calif. BioTime, Inc. (NYSE MKT: BTX) and its subsidiary OncoCyte Corporation today announced that OncoCyte has initiated clinical development of its bladder cancer diagnostic test in both...
View ArticleThe Belmont® Rapid Infuser Expands Distribution to Japan
BILLERICA, Mass. Belmont Instrument Corporation announced this week that the Belmont® Rapid Infuser has been approved for use in Japan and will begin distributing the device through its partnership...
View ArticleCovidien Receives Japanese Regulatory Approval for Reinforced Stapling Reload...
DUBLIN, Ireland Covidien plc (NYSE: COV) today announced that its Japanese subsidiary, Covidien Japan Inc., has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare for...
View Article